Insect Cell Line Market
Number of pages: 100 | Report Format: PDF | Published date: May 16, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 875.65 million |
|
Revenue Forecast in 2031 |
US$ 2,313.64 million |
|
CAGR |
11.40% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global insect cell line market was valued at US$ 875.65 million in 2022 and is expected to register a revenue CAGR of 11.40% to reach US$ 2,313.64 million by 2031.
Insect Cell Line Market Fundamentals
Insect cell lines are important tools in researching insect biology, understanding host-pathogen relationships, and creating recombinant proteins in a variety of disciplines of research and business. These cell lines are derived from insect embryos or tissues, with various benefits, including simplicity of culture, rapid growth rates, and the potential to express foreign genes. Insect cells are compatible with many viral vectors, making them excellent for creating viral-based vaccinations and gene treatments. Insect cell lines have proven crucial in expanding the overall understanding of insect physiology and helping to develop novel biotechnological solutions due to their variety and prospective uses. Recently, there has been an increasing focus on using genome editing technologies, such as CRISPR-Cas9, to engineer insect cell lines for improved protein expression, glycosylation patterns, and other desired traits. These advances enable the generation of cell lines with enhanced productivity and specific functionalities, making them more attractive for industrial applications.
The research study on the insect cell line market overview thoroughly analyzes the market, along with the aspects that either help or hinder the market's growth, such as its drivers, challenges, and opportunities. The research also discusses the list of businesses that operate in this market and their efforts to establish themselves as major players through expansion plans and innovative ideas. It also emphasizes current events that support the market's revenue expansion. The research also analyses how the COVID-19 pandemic has affected society.
This report is an important tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other valuable data to help make informed strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide in-depth insect cell line market forecast to the industry stakeholders.
[75675]
Insect Cell Line Market Dynamics
Insect cells have become a popular choice for producing recombinant proteins due to their ability to perform post-translational modifications essential for many therapeutic proteins' functionality. Additionally, insect cell lines offer advantages such as high yield, scalability, and cost-effectiveness compared to traditional mammalian cell lines. For instance, the recent demonstration of CRISPR in Sf9, the publication of the Sf9 and High Five genomes, and the foundational CRISPR developments in Drosophila and Bombyx have proved to be a new and exciting direction for virus-less engineering of insect cells. CRISPR has been innovatively adopted in a wide range of cell types and is expected to initiate a rapid expansion of engineering strategies to achieve high-level expression of multiple genes in insect cells. The insect cell line market is expected to continue to grow as more companies and researchers turn to this technology for the production of biologics. Moreover, insect cell lines are becoming increasingly popular as a viable alternative to traditional animal-derived components in cell culture media due to their cost-effectiveness, scalability, and ethical considerations. As the demand for animal-free cell culture grows, insect cell lines will likely play an increasingly important role in the biopharmaceutical industry.
However, high production costs, regulatory challenges, and limited availability of qualified personnel are major restraining factors in the global insect cell line market.
Insect Cell Line Market Ecosystem
Insect Cell Line Market, by Product
Insect Cell Line Market, by Application
Insect Cell Line Market, by End User
Insect Cell Line Market by Product
[85654]
The S2 segment has dominated the insect cell line market with the most revenue share. The S2 insect line segment is the most commonly used insect cell lines in research methodology. The S2 insect line segment is preferred due to its ability to produce high yields of recombinant proteins and its adaptability to serum-free media. In addition, the S2 insect cell line is known for its fast growth rate and genetic stability, making it a reliable choice for large-scale protein production. Using the S2 insect cell line can result in significant cost savings and increased efficiency in biopharmaceutical manufacturing.
The high five segment is expected to register 12.2% of revenue CAGR in the forecast years. This is majorly due to high growth rates, low susceptibility to viral contamination, ease of genetic manipulation, and the ability to produce complex proteins with post-translational modifications. These features make high five insect cell lines a valuable tool for various applications in the fields of biotechnology, pharmaceuticals, and basic research.
Segmentation of the market refers to the division of the industry into subgroups based on factors such as product, application, end user, and region. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential insect cell line market growth opportunities.
Insect Cell Line Market by Region
North America dominated the insect cell line market with a revenue share of approximately 36% due to its high demand for insect cell-based vaccines and therapeutics and the increasing investments in research and development activities. In addition, the availability of advanced technologies for insect cell culture and the presence of well-established healthcare infrastructure in North America are also contributing to the revenue growth of the insect cell line market. Furthermore, the growing adoption of insect cell lines in drug discovery and development processes is expected to drive the market revenue growth in the forecast years.
The Asia Pacific region is expected to show high revenue growth in the forecast years due to increasing research and development, technological advancements, and growing demand for innovative products and services. The Asia Pacific region also presents numerous opportunities for businesses looking to expand their operations and increase their revenue growth.
Based on the regions, the global insect cell line market is segmented into:
Regional demarcation of the industry will provide information on geographic pockets regarding insect cell line market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies.
Key Components of the Report
Insect Cell Line Market Competitive Landscape
Some of major market players in the insect cell line market are:
The market competitive landscape is performed by collecting and analyzing information about the key competitors, the present industry trends, and market dynamics. It includes information collection and analysis on factors such as products, pricing, geographic outreach, customer demographics, marketing strategies, and recent developments. Competitive landscape assessment will help businesses identify the current prevalent or potential opportunities and threats, keeping in mind the insect cell line industry trends.
Insect Cell Line Market Strategic Developments
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Reasons to Buy this Report
An insect cell line refers to a group of cells derived from insects and used for research purposes, such as protein expression and virus production. These cells are widely used in biotechnology and pharmaceutical industries due to their ability to produce large quantities of recombinant proteins.
The global insect cell line market was valued at US$ 875.65 million in 2022.
Asia Pacific region will have the largest insect cell line market size during the forecast period from 2023 to 2031.
The global insect cell line market is expected to register a revenue CAGR of 11.40% during the forecast period from 2023 to 2031.
The global insect cell line market is expected to register US$ 2,313.64 million by 2031.
The use of insect cell lines has become increasingly popular in the biotechnology industry due to their ability to produce complex proteins and vaccines. This trend is expected to continue as researchers explore new applications for these versatile cells.
The global insect cell line market is expected to experience significant growth in the coming years due to the increasing demand for insect cell-based products in biopharmaceutical research and development. The rise in investments by key players in the market and technological advancements are also contributing factors to this growth.
The high production costs, regulatory challenges, and limited availability of qualified personnel are major restraining factors in the global insect cell line market.
Product innovation, strategic partnerships and collaborations, mergers and acquisitions, and expanding their geographical presence are the major strategies adopted by key market players.
*Insights on financial performance are subject to the availability of information in the public domain